Joel Moss
Overview
Explore the profile of Joel Moss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
336
Citations
7520
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fontana J, Moss J, Kim D, Stylianou M, Levine S, Barochia A, et al.
Am J Respir Crit Care Med
. 2024 Dec;
211(3):515-518.
PMID: 39701029
No abstract available.
2.
Yang B, Elinoff J, Campbell-Washburn A, Wen H, Moss J
Chest
. 2024 Nov;
PMID: 39580110
Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease affecting women and is characterized by the proliferation of abnormal smooth muscle-like cells within the lungs, kidneys, and lymphatic system. FEV and...
3.
Ozaki K, Nagahara H, Kawamura A, Ohgita T, Higashi S, Ogura K, et al.
Toxins (Basel)
. 2024 Sep;
16(9).
PMID: 39330838
is an important foodborne pathogen. Cholix cytotoxin (Cholix), produced by , is a novel eukaryotic elongation factor 2 (eEF2) adenosine diphosphate ribosyltransferase that causes host cell death by inhibiting protein...
4.
Baral A, Lee S, Hussaini F, Matthew B, Lebron A, Wang M, et al.
Diagnostics (Basel)
. 2024 Jul;
14(14).
PMID: 39061666
In cystic lung diseases such as lymphangioleiomyomatosis (LAM), a CT-based cyst score that measures the percentage of the lung volume occupied by cysts is a common index of the cyst...
5.
Child C, Ho L, Lachant D, Gupta N, Moss J, Jones A, et al.
Chest
. 2024 Jul;
166(5):1108-1123.
PMID: 39025205
Background: Little research is available to provide practical guidance to health care providers for exercise preparticipation screening and referral of patients with interstitial lung diseases (ILDs), including lymphangioleiomyomatosis (LAM), to...
6.
Gibbons E, Taya M, Wu H, Lopa S, Moss J, Henske E, et al.
Endocr Relat Cancer
. 2024 Apr;
31(6).
PMID: 38614127
Lymphangioleiomyomatosis (LAM) is a rare, progressive cystic lung disease affecting almost exclusively female-sexed individuals. The cysts represent regions of lung destruction caused by smooth muscle tumors containing mutations in one...
7.
Kasamatsu A, Nozaki R, Kawasaki K, Saito T, Minemura C, Seki N, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539573
microRNAs (miRs) function in cancer progression as post-transcriptional regulators. We previously reported that endogenous circular RNAs (circRNAs) function as efficient miR sponges and could act as novel gene regulators in...
8.
Golbus A, Steveson C, Schuzer J, Rollison S, Worthy T, Jones A, et al.
Eur Radiol
. 2024 Feb;
34(9):5613-5620.
PMID: 38388717
Purpose: Frequent CT scans to quantify lung involvement in cystic lung disease increases radiation exposure. Beam shaping energy filters can optimize imaging properties at lower radiation dosages. The aim of...
9.
10.
Lee S, Lebron A, Matthew B, Moss J, Wen H
Bioengineering (Basel)
. 2023 Nov;
10(11).
PMID: 38002379
(1) Background: Lymphangioleiomyomatosis is a genetic disease that affects mostly women of childbearing age. In the lungs, it manifests as the progressive formation of air-filled cysts and is associated with...